Benzinga

APRIL 22, 2024

Cannabis giant Curaleaf Holdings, Inc. (TSX: Terms of the acquisition of NGC include an initial payment at closing of the company’s subordinate voting shares valued at approximately $16 million, subject to a typical post-closing adjustment. Full story available on Benzinga.com

Marketability 118

Marketability 118

Benzinga

APRIL 17, 2024

The company’s latest move to further cement its global footprint comes on the heels of a new German cannabis law that went into effect on April 1, which partially legalizes cannabis by allowing adults over 18 to possess up to 25 grams of dried cannabis and grow three marijuana plants at home. NASDAQ: TLRY ) and Curaleaf Holdings Inc.

Marketability 105

Marketability 105

Benzinga

MARCH 19, 2024

Curaleaf Holdings, Inc. The company also partners with Canadian GACP cultivators to produce and distribute finished cannabis products to the domestic and global markets. The company also partners with Canadian GACP cultivators to produce and distribute finished cannabis products to the domestic and global markets.

Marketability 69

Marketability 69

Benzinga

FEBRUARY 6, 2024

Curaleaf International, part of cannabis giant Curaleaf Holdings Inc (OTCQX: CURLF ) (TSX: CURA ), has expanded in Poland via the acquisition of Can4Med, the country's pharmaceutical wholesaler specializing in cannabinoid medications. See also: Cannabis In Poland: Medical Marijuana, Inc.’s

59

59

Law 360 M&A

DECEMBER 15, 2023

has settled its February lawsuit against cannabis company Cura Partners Inc. that asserted to an Oregon federal court that Hallmark shouldn't have to cover an underlying suit related to the sale of one of Cura Partners' subsidiaries to Curaleaf Holdings Inc. Hallmark Speciality Insurance Co.

52

52

Benzinga

OCTOBER 5, 2022

Curaleaf Holdings, Inc. CSE: CURA) (OTCQX: CURLF ) completed its previously announced acquisition of Tryke Companies (dba as Reef Dispensaries), a privately held vertically integrated, multi-state cannabis operator. " Matt Darin , CEO of Curaleaf, said, "As we continue to unite the strength.

EBITDA 52

EBITDA Marketability 52

Benzinga

SEPTEMBER 2, 2022

Zuanic said the deal between Curaleaf Holdings Inc. NASDAQ: CRBLF) and Four20 Pharma stands out from the rest, because it could have the greatest long term strategic implications “especially if Curaleaf international goes for a NASDAQ listing (in the event US MSOs do not have a line of sight on listing themselves).

Dividends 98

Dividends Marketability 98